S. Broersen

发表

Relation of phenotype evolution of HIV-1 to envelope V2 configuration.

H. Schuitemaker, R. Fouchier, F. Miedema, 1993, Science.

The role of a stromal cell‐derived factor‐1 chemokine gene variant in the clinical course of HIV‐1 infection

H. Schuitemaker, J. Goudsmit, R. V. van Rij, 1998, AIDS.

Envelope V2 configuration and HIV-1 phenotype: clarification.

H. Schuitemaker, A. B. van 't Wout, R. Fouchier, 1995, Science.

Cytopathic Effects of Non-Syncytium-Inducing and Syncytium-Inducing Human Immunodeficiency Virus Type 1 Variants on Different CD4+-T-Cell Subsets Are Determined Only by Coreceptor Expression

H. Schuitemaker, D. Kwa, B. Boeser-Nunnink, 2001, Journal of Virology.

Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.

H. Schuitemaker, A. M. de Roda Husman, R. V. van Rij, 1999, The Journal of infectious diseases.

Reduction of HTLV-I-infected cells in blood by leukocyte filtration

S. Stienstra, S. Broersen, J. Huisman, 1993, Annals of Hematology.

Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albumins.

H. Schuitemaker, D. Meijer, M. Kuipers, 1997, AIDS research and human retroviruses.

Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection

H. Schuitemaker, I. Keet, M. Prins, 1997, Annals of Internal Medicine.

Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR

H. Schuitemaker, R. Fouchier, M. Brouwer, 1995, Journal of clinical microbiology.

Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain

H. Schuitemaker, R. Fouchier, A. Andeweg, 1992, Journal of virology.

Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment

J. Moore, H. Schuitemaker, M. Groenink, 1995, Journal of virology.

Reversal of Human Immunodeficiency Virus Type 1 IIIB to a Neutralization-Resistant Phenotype in an Accidentally Infected Laboratory Worker with a Progressive Clinical Course

W. Blattner, H. Schuitemaker, T. Beaumont, 2001, Journal of Virology.

Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.

H. Schuitemaker, A. M. de Roda Husman, R. V. van Rij, 2000, The Journal of clinical investigation.

Increased Neutralization Sensitivity and Reduced Replicative Capacity of Human Immunodeficiency Virus Type 1 after Short-Term In Vivo or In Vitro Passage through Chimpanzees

H. Schuitemaker, J. Heeney, T. Beaumont, 2000, Journal of Virology.

Temporal relationship between elongation of the HIV type 1 glycoprotein 120 V2 domain and the conversion toward a syncytium-inducing phenotype.

H. Schuitemaker, R. Fouchier, A. V. van’t Wout, 1995, AIDS research and human retroviruses.

The role of a stromal cell‐derived factor‐1 chemokine gene variant in the clinical course of HIV‐1 infection

H. Schuitemaker, R. V. van Rij, R. Coutinho, 1998, AIDS.

Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

Brouwer, H. Schuitemaker, H. Blaak, 2000, The Journal of clinical investigation.